Effectiveness of Second-Dose Varicella Vaccination As Post-Exposure Prophylaxis: a Prospective Cohort Study.

Q. Wu,J. Liu,Y. Wang,Q. Zhou,X. Wang,Z. Xuan,L. Zhang,Y. Gao,B. Chen,Y. Hu

DOI: https://doi.org/10.1016/j.cmi.2018.11.013

IF: 13.31

2018-01-01

Clinical Microbiology and Infection

Abstract:Objectives: Although administration of a second dose of varicella vaccine (2nd-dose VarV) to individuals who have previously received one-dose VarV has been recommended as a post-exposure prophylaxis (PEP) strategy for outbreak control, the effectiveness of this strategy remains unclear. We evaluated the vaccine effectiveness (VE) of 2nd-dose VarV as PEP among students involved in 129 varicella outbreaks in Shanghai, China from 2013 to 2016. Methods: Students who had received one-dose VarV more than 5 years prior to varicella exposure were eligible to receive 2nd-dose VarV as PEP. We evaluated the VE using the following formula: VE = (1 - hazard ratio (HR)) x 100%. Results: A total of 6762 students were eligible for 2nd-dose VarV, of whom 58.6% accepted PEP after varicella exposure. The adjusted VE of 2nd-dose VarV as PEP was 77% (95% confidence interval 64-85%). In addition, the adjusted VE of 2nd-dose VarV as PEP in affected classrooms with high vaccine uptake was higher than that in classrooms with lower vaccine uptake (87% vs. 69%). The adjusted VE was also higher in students who received 2nd-dose VarV within 3 days of exposure than those who received it more than 3 days post exposure (77% vs. 64%). Conclusions: These Results suggest that administration of 2nd-dose VarV as PEP is an appropriate intervention for outbreak control in countries where two-dose VarV has not been adopted. (C) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.